Key Figures

Key Figures for the First Half of 2017

In millions of € unless otherwise specified
  Group Bioprocess Solutions Lab Products & Services
  6-mo. 2017 6-mo. 2016 Δ in % reported 6-mo. 2017 6-mo. 2016 Δ in % reported 6-mo. 2017 6-mo. 2016 Δ in % reported
Sales Revenue and Order Intake
Sales revenue 704.1 625.4 12.6 510.9 469.8 8.8 193.2 155.7 24.1
Order intake 741.9 677.6 9.5 546.9 519.2 5.3 195.0 158.4 23.1
Result         
EBITDA1 174.5 153.4 13.8 140.8 128.1 10.0 33.7 25.3 33.1
EBITDA-margin1 in % 24.8 24.5   27.6 27.3   17.5 16.3  
Net result2 70.9 62.4 13.6            
Financial Data per Share
Earnings per ord. share2 in € 1.03 0.91 13.7            
Earnings per pref. share2 in € 1.04 0.92 13.6            
30.06.201731.12.2016
Balance Sheet | Financials
Balance sheet total2,291.71,753.0
Equity747.2736.8
Equity ratio in %32.642.0
Net debt919.8485.9
Net debt | underlying EBITDA2.71.5

Key Figures for the Second Quarter of 20173

In millions of € unless otherwise specified
Group Bioprocess Solutions Lab Products & Services
  Q2
2017
Q2
2016
Δ in %
reported
Q2
2017
Q2
2016
Δ in %
reported
Q2
2017
Q2
2016
Δ in %
reported
Sales Revenue and Order Intake
Sales revenue 361.0 323.5 11.6 259.8 242.8 7.0 101.2 80.7 25.4
Order intake 365.0 347.5 5.0 263.4 265.0 -0.6 101.6 82.5 23.2
Result         
EBITDA1 89.9 81.1 10.9 72.5 67.1 8.0 17.5 14.0 25.0
EBITDA-margin1 in % 24.9 25.1   27.9 27.6   17.3 17.3  
Net result2 36.5 33.1 10.1            
Financial Data per Share
Earnings per ord. share2 in € 0.53 0.48 10.1            
Earnings per pref. share2 in € 0.53 0.48 10.1            

1 Excluding extraordinary items

2 After non-controlling interest, adjusted for extraordinary items as well as non-cash amortization, and based on the normalized financial result as well as the corresponding tax effects for each of these items

3 Figures are not audited nor reviewed